Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea after moving to the 5mg dose of Mounjaro is genuinely common, and it usually settles within a couple of weeks as your body adjusts to a higher level of tirzepatide. That said, 'common' does not mean 'ignore it' — there are specific symptoms that need medical attention promptly. Mounjaro is a prescription-only medicine, and any change to how you're tolerating it is worth discussing with the prescriber who oversees your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common thing people assume when nausea arrives with the 5mg pen is that they have moved up too quickly, or that their body is rejecting the medicine. In practice, nausea at this stage usually means the dose is working exactly as it should. Tirzepatide slows gastric emptying (food leaves the stomach more slowly) and it acts on satiety signals in the brain. Both effects are dose-dependent, so when the dose rises from 2.5mg to 5mg, the gut notices.
That adjustment period is real, but it is not a signal to stop or to request a lower dose by default. The 2.5mg starter dose exists specifically to let the body ease into tirzepatide's mechanism before the first increase; the 5mg step asks the system to recalibrate again. Most people find the nausea at this stage is worse in the first few days of a new pen, then quieter by week three or four. A few practical things help: smaller meals, eating slowly, avoiding rich or fatty food, and not lying flat immediately after eating. None of that is glamorous advice, but it works for most people.
If you are still finding 5mg very difficult to tolerate after four to six weeks, that is worth raising with your prescriber. It may be appropriate to stay at this dose a little longer before considering whether the 7.5mg step is right for you, but that decision belongs with the clinician, not a forum thread.
Textbook 5mg nausea is: queasiness in the first day or two after injecting, an aversion to food you normally enjoy, the occasional bout of actual vomiting (particularly if you ate a large or fatty meal), and burping or indigestion that wasn't there before. The NHS tirzepatide medicines page lists all of these as known, expected side effects. They are uncomfortable. They are not dangerous on their own.
The symptoms that are different in character (and that need same-day or emergency assessment) are worth knowing clearly. Severe stomach pain that does not ease, especially if it radiates toward your back, is not GI adjustment; it could indicate acute pancreatitis. The MHRA's Drug Safety Update issued in January 2026 specifically highlighted this risk across GLP-1 medicines and asked that patients seek urgent help for that presentation. Signs of significant dehydration from repeated vomiting (dizziness, very dark urine, confusion, inability to keep any fluids down) also need medical contact. And any allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat) is a 999 situation.
The distinction matters because pancreatitis, while uncommon, can be serious if not treated promptly. Report any suspected serious side effect through the MHRA Yellow Card scheme, it is open to patients as well as clinicians, and your report contributes to the post-market safety picture for a medicine still under additional MHRA monitoring.
When you inject, and what you eat around it, genuinely affects how much nausea you feel. Many people find that injecting in the evening (with a lighter meal) means the worst of the queasiness happens overnight rather than during a working day. There is no single right answer, but it is worth experimenting across the first couple of pens before assuming the timing cannot be adjusted. (If you are starting a new pen around a bank holiday or a week when your routine shifts, that unpredictability in meal timing can amplify symptoms, worth factoring in.)
Protein at most meals helps maintain muscle alongside the calorie reduction; it also tends to be better tolerated than heavy, fatty food when nausea is high. Small frequent meals outperform three large ones at this stage. Cold or room-temperature food often causes less queasiness than hot dishes, simply because steam and strong aromas can tip an already-sensitive stomach. These are practical adjustments, not medical instructions, your prescriber or the Patient Information Leaflet that comes with the Mounjaro 5mg pen is the right reference for guidance specific to your situation.
Hydration is straightforward but easy to forget when eating is unappealing. Sipping water steadily across the day (rather than large amounts at once) sits better with a slowed stomach. If nausea is making it genuinely difficult to drink enough, that is the point at which you contact your prescriber, not a reason to push through independently.
Persistent or severe nausea that does not ease by week four or five is a clinical question, not a personal failing. A prescriber reviewing your case might consider whether the titration timing needs adjusting, whether there is an interaction with another medicine you take, or whether a different approach to the dose schedule suits your circumstances better. They will also want to rule out anything unrelated to Mounjaro, it is easy to attribute every symptom to the new medicine, but a prescriber's job is to look at the full picture.
At nume, every repeat prescription involves a clinical review before any dose change is authorised. Our prescribers talk through side effects as part of the standard consultation, and that includes working out whether nausea at the 5mg step is something to manage or something to take seriously. You can read more about the 5mg dosing stage and how the titration schedule is structured, or visit the main Mounjaro information page for a broader overview. If you have questions about starting treatment, our clinical team profile is at the prescribers page. For anything that needs a conversation sooner, our support team is reachable seven days a week.
These are prescription-only medicines for good reason. If you are considering starting, or thinking about switching from a current provider, start your free consultation and a prescriber will discuss suitability and side effects with you directly before anything is prescribed. Patients who are further along in their titration journey and want to understand the higher-strength formulation can also find out more about tirzepatide peptides 10mg, including how it differs from the earlier doses.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.